Skip to main content

Advertisement

ADVERTISEMENT

November 2020 Table of Contents

November 2020

Original Contribution

Clinical Outcomes of the Portico Transcatheter Aortic Valve Delivered via Alternative Access: 30-Day and 1-Year Results of the Portico ALT Study

Marleen van Wely, MD; Giuseppe Bruschi, MD, PhD; Francesco Bedogni, MD, PhD; Holger Thiele, MD, PhD; Raban V. Jeger, MD, PhD; Kees van der Wulp, MD; Lars Soendergaard, MD, PhD; Joerg Kempfert, MD, PhD; Christian Schlensak, MD, PhD; Axel Linke, MD, PhD

The aim of this study was to report the 30-day and 1-year outcomes and performance from the Portico Alternative Access study, a multicenter, prospective, non-randomized, investigational study describing 45 patients with severe symptomatic aortic valve stenosis treated with the self-expanding Portico device using subclavian/axillary access. The primary study endpoint was the rate of major vascular complications at 30 days.  

J INVASIVE CARDIOL 2020;32(11):405-411. Epub 2020 August 10. 


Original Contribution

Safety and Outcome of Rheolytic Thrombectomy for the Treatment of Acute Massive Pulmonary Embolism

Francesco Pelliccia, MD, PhD; Alessandra De Luca, MD; Vincenzo Pasceri, MD, PhD; Gaetano Tanzilli, MD; Giulio Speciale, MD; Carlo Gaudio, MD

Percutaneous rheolytic thrombectomy is an attractive alternative to thrombolytic therapy in patients with acute pulmonary embolism, but its use is currently discouraged due to safety concerns. We studied 33 consecutive patients with acute pulmonary embolism and contraindications to thrombolytic therapy who had rheolytic thrombectomy with the AngioJet catheter. The primary endpoint was the frequency of complications of rheolytic thrombectomy; specific attention was also paid to the occurrence of anemia and renal failure.

J INVASIVE CARDIOL 2020;32(11):412-416.


Original Contribution

Outcomes of Patients Turned Down for Percutaneous Mitral Valve Repair

Binyamin B. Neeman; Elad Maor, MD, PhD; Israel M. Barbash, MD; Ilan Hai, MD; Ori Vaturi, MD; Sagit Ben Zekry, MD; Amit Segev, MD; Micha Feinberg, MD; Victor Guetta, MD; Paul Fefer, MD

Percutaneous mitral valve repair is an alternative treatment for high-risk patients with symptomatic mitral regurgitation. Our study aimed to assess the reasons for and outcomes of patients who were declined MitraClip implantation and compare them with patients who underwent the procedure. The primary endpoint for efficacy was freedom from death.

J INVASIVE CARDIOL 2020;32(11):417-421. Epub 2020 July 10.


Original Contribution

Sex-Specific Outcomes of Patients Treated With Extracorporeal Cardiopulmonary Resuscitation

Bernhard Wernly, MD, PhD; Sandra Büter, MD; Maryna Masyuk, MD; Diyar Saeed, MD; Alexander Albert, MD; Georg Fuernau, MD; Hug Aubin, MD; Malte Kelm, MD; Ralf Westenfeld, MD; Christian Jung, MD, PhD

Patients after cardiac arrest treated with extracorporeal cardiopulmonary resuscitation (eCPR) evidence high mortality. Recently, women were reported to evidence even worse outcomes after cardiac arrest. However, sex-specific data on cardiac arrest patients treated with eCPR are lacking. We therefore aimed to evaluate potential sex differences in risk distribution, management, and outcomes in patients treated with eCPR. Sixty-four patients — 16 females (25%) and 48 males (75%) — with complete data were retrospectively included in this analysis.

J INVASIVE CARDIOL 2020;32(11):422-426. Epub 2020 July 10.


Original Contribution

Percutaneous Balloon Mitral Valvuloplasty During Antenatal Care and Apgar Score: The ANC-Valve Study

Vaibhav Bansidhar Patil, MD, DM and Suresh Patted, MD, DM

The present study aimed to evaluate maternal and fetal outcomes in patients who underwent percutaneous balloon mitral valvuloplasty (PBMV) during antenatal care. We studied demographic, clinical, echocardiographic, hemodynamic, and Doppler examinations of 117 pregnant women who underwent PBMV for rheumatic mitral stenosis. 

J INVASIVE CARDIOL 2020;32(11):427-432. 


Original Contribution

Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes

Iosif Xenogiannis, MD; Ilias Nikolakopoulos, MD; Oleg Krestyaninov, MD; Dmitrii Khelimskii, MD; Jaikirshan J. Khatri, MD; Anthony H. Doing, MD; Phil Dattilo, MD; Khaldoon Alaswad, MD; Catalin Toma, MD; Abdul M. Sheikh, MD; Farouc A. Jaffer, MD, PhD; Brian K. Jefferson, MD; Taral Patel, MD; Raj H. Chandwaney, MD; Wissam Jaber, MD; Habib Samady, MD; Mitul Patel, MD; Ehtisham Mahmud, MD; James Choi, MD; Michalis Koutouzis, MD; Ioannis Tsiafoutis, MD; Michael Megaly, MD; Mohamed Omer, MD; Evangelia Vemmou, MD; Bavana V. Rangan, BDS, MPH; Santiago Garcia, MD; Shuaib Abdullah, MD; Subhash Banerjee, MD; Nicholas Burke, MD; Emmanouil S. Brilakis, MD, PhD; Dimitri Karmpaliotis, MD, PhD

The impact of chronic total occlusion percutaneous coronary intervention (CTO-PCI) on angina and subsequent incidence of major adverse cardiovascular event (MACE) remains controversial. We compared patient-reported angina change and the incidence of MACE between successful vs failed CTO-PCI in 1612 patients in a large, multicenter registry. 

J INVASIVE CARDIOL 2020;32(11):433-439. Epub 2020 June 22.


Original Contribution

Music Can Reduce the Need for Pharmacologic Conscious Sedation During Invasive Coronary Angiography

Ramin Ebrahimi, MD; A. Laurie Shroyer, PhD; Paul Dennis, PhD; Jesse Currier, MD; Dora Lendvai Wischik, RN

Opiates and benzodiazepines are commonly used during invasive coronary angiography to address pain and anxiety. In the United States, these medications are used in more than 90% of such cases. We aimed to evaluate the impact of music on levels of pain and anxiety in patients undergoing invasive coronary angiography.

J INVASIVE CARDIOL 2020;32(11):440-444. Epub 2020 October 22.


Original Contribution 

On-Site Computed Tomography Versus Angiography Alone to Guide Coronary Stent Implantation: A Prospective Randomized Study

Maksymilian P. Opolski, MD, PhD*; Stefan P. Schumacher, MD*; Niels J.W.  Verouden, MD, PhD; Pepijn A. van Diemen, MD; Bartosz A. Borucki, MSc; Ralf Sprengers, MD, PhD; Henk Everaars, MD; Ruben W. de Winter, MD; Albert C. van Rossum, MD, PhD; Alexander Nap, MD, PhD; Michiel J. Bom, MD; Paul Knaapen, MD, PhD     *Joint first authors

The effect of intraprocedural coronary computed tomography angiography (CTA) guidance on PCI is unknown. We sought to determine the influence of CTA guidance on procedural strategies and immediate angiographic outcomes of PCI. Sixty patients were randomized to CTA-guided PCI (29 patients, 36 lesions) or angiography-guided PCI (31 patients, 39 lesions).

J INVASIVE CARDIOL 2020;32(11):E268-E276. Epub 2020 September 10.


Original Contribution

Clinical and Echocardiographic Features Associated With Improved Survival in Patients With Severe Aortic Stenosis Undergoing Balloon Aortic Valvuloplasty (BAV)

Mustafa Husaini, MD; Yuko Soyama, MD, PhD; Nobuyuki Kagiyama, MD, PhD; Prashanth Thakker, MD; Manoj Thangam, MD; Nowrin Haque, MD; Elena Deych, MS; Marc Sintek, MD; John Lasala, MD, PhD; John Gorcsan III, MD; Alan Zajarias, MD

Our objective was to identify features to help identify patients likely to benefit from balloon aortic valvuloplasty. 

J INVASIVE CARDIOL 2020;32(11):E277-E285. 


Brief Communication

Serial Dilation of Low-Profile Stents Delivered in the Aorta and Pulmonary Arteries in Pediatric Patients Leads to Spontaneous Fractures but Not to Adverse Events

Peter W. Guyon Jr, MD; Bryan P. Mosher, MD, PhD; Yiran Zhang, MS; Kanishka Ratnayaka, MD; John W. Moore, MD; Howaida G. El-Said, MD, PhD

Low-profile stents placed in pediatric patients with congenital heart disease must be expanded by balloon angioplasty to accommodate patient growth. We report the performance characteristics and safety profile of a cohort of low-profile, premounted stents placed in the pulmonary arteries and aorta and then serially dilated over time, including incidence of fracture and any adverse events. 

J INVASIVE CARDIOL 2020;32(11):E286-E294. 


Brief Communication

Iatrogenic Atrial Septal Defect After Percutaneous Mitral Valve Repair With MitraClip: Should We Consider Closing Them Routinely?

Ariana Gonzálvez-García, MD; Alfonso Jurado-Román, MD, PhD; Harold Hernández-Matamoros, MD; Santiago Jiménez-Valero, MD; Guillermo Galeote, MD, PhD; Raúl Moreno, MD, PhD; José Luis López-Sendón, MD, PhD

Percutaneous MitraClip intervention for treatment of severe mitral regurgitation in high surgical risk patients requires large-diameter transseptal sheaths that can result in iatrogenic atrial septal defect (iASD). We describe our experience with 2 patients who required iASD closure after MitraClip procedure.

J INVASIVE CARDIOL 2020;32(11):E295-E297. 


Rapid Communication

Dose-Tracking System as a Tool to Manage Radiation Exposure

Cristiano de Oliveira Cardoso, MD, PhD, MBA; Thiago Eiti Ishihara; Cristiane Cauduro Lima, RN; Clacir Staudt, MD

We describe the use of a radiation dose-tracking system (Canon Medical Systems) that can help physicians provide patients with better care after higher radiation exposure dose following lengthy procedures.

J INVASIVE CARDIOL 2020;32(11):E298. 


Clinical Images

Iatrogenic Pneumopericardium During Pericardiocentesis

Sourabh Agstam, MBBS, MD, DM; Anunay Gupta, MBBS, MD, DM; Preeti Gupta, MBBS, MD, DNB; Tushar Agarwal, MBBS, MD

J INVASIVE CARDIOL 2020;32(11):E299. 


Clinical Images

Successful Percutaneous Closure of Periprosthetic Mitral Pseudoaneurysm Using a Duct Occluder Device

Ainhoa Pérez Guerrero, MD;  Gabriel Galache Osuna, MD;  Georgina Fuertes Ferre, MD;  Eva Moreno Esteban, MD;  Jose Antonio Diarte De Miguel, MD

J INVASIVE CARDIOL 2020;32(11):E300.


Clinical Images

Everolimus-Eluting Stent Causing Coronary Artery Aneurysm in 7 Days: 3D-OCT Findings and Management

Ankush Gupta, MD, DM;  Sanya Chhikara, MBBS;  Rajat Datta, MD, DM;  Rajesh Vijayvergiya, MD, DM

J INVASIVE CARDIOL 2020;32(11):E301-E302. 


Clinical Images

Spontaneously Sealed Forearm Radial Artery Perforation During a Left Distal Transradial Coronary Intervention

Marcos Danillo P. Oliveira, MD;  Thalita Ruolla Barros, MD;  Adriano Caixeta, MD, PhD

J INVASIVE CARDIOL 2020;32(11):E303-E304. 


Advertisement

Advertisement

Advertisement